Pan-Cancer (N=930) | HB-Cancer (N=1151) | Pan-disease (N=4409) | HB-disease (N=21002) | Control (N=5895) | Total (N=33387) | p value | |
---|---|---|---|---|---|---|---|
Gender | < 0.0011 | ||||||
   Female | 439 (47.2%) | 430 (37.4%) | 2043 (46.3%) | 11186 (53.3%) | 1681 (28.5%) | 15779 (47.3%) | |
   Male | 491 (52.8%) | 721 (62.6%) | 2366 (53.7%) | 9816 (46.7%) | 4214 (71.5%) | 17608 (52.7%) | |
Ethnicity | < 0.0011 | ||||||
   White | 519 (66.6%) | 549 (53.7%) | 2370 (57.6%) | 10396 (51.5%) | 3280 (57.7%) | 17114 (53.9%) | |
   South Asian | 79 (10.1%) | 230 (22.5%) | 874 (21.2%) | 5207 (25.8%) | 942 (16.6%) | 7332 (23.1%) | |
   Black | 98 (12.6%) | 121 (11.8%) | 408 (9.9%) | 2046 (10.1%) | 806 (14.2%) | 3479 (10.9%) | |
   Far/South-east Asian | 4 (0.5%) | 24 (2.3%) | 19 (0.5%) | 234 (1.2%) | 31 (0.5%) | 312 (1.0%) | |
   Arab/North African | 0 (0.0%) | 0 (0.0%) | 1 (0.0%) | 15 (0.1%) | 5 (0.1%) | 21 (0.1%) | |
   Asian (Other) | 17 (2.2%) | 46 (4.5%) | 178 (4.3%) | 970 (4.8%) | 234 (4.1%) | 1445 (4.5%) | |
   Mixed | 9 (1.2%) | 8 (0.8%) | 49 (1.2%) | 241 (1.2%) | 78 (1.4%) | 385 (1.2%) | |
   Other | 53 (6.8%) | 45 (4.4%) | 217 (5.3%) | 1065 (5.3%) | 306 (5.4%) | 1686 (5.3%) | |
Diagnosis age (years) | < 0.0012 | ||||||
   Mean (SD) | 66.91 (12.72) | 65.24 (13.22) | 52.90 (18.51) | 53.64 (17.67) | 54.77 (17.59) | 54.51 (17.77) | |
   Median | 67.21 | 66.06 | 51.28 | 52.42 | 54.09 | 53.62 | |
   Q1,Q3 | 58.88, 76.07 | 56.79, 75.15 | 38.36, 67.20 | 39.90, 66.40 | 41.02, 68.00 | 40.66, 67.85 | |
Diagnosis age group | < 0.0011 | ||||||
   18-40 | 27 (2.9%) | 54 (4.7%) | 1318 (29.9%) | 5663 (27.0%) | 1470 (24.9%) | 8532 (25.6%) | |
   41-50 | 66 (7.1%) | 100 (8.7%) | 862 (19.6%) | 4149 (19.8%) | 1097 (18.6%) | 6274 (18.8%) | |
   51-60 | 189 (20.3%) | 266 (23.1%) | 773 (17.5%) | 4186 (19.9%) | 1163 (19.7%) | 6577 (19.7%) | |
   61-70 | 290 (31.2%) | 325 (28.2%) | 574 (13.0%) | 3022 (14.4%) | 961 (16.3%) | 5172 (15.5%) | |
   71-80 | 234 (25.2%) | 273 (23.7%) | 519 (11.8%) | 2311 (11.0%) | 733 (12.4%) | 4070 (12.2%) | |
   >80 | 124 (13.3%) | 133 (11.6%) | 363 (8.2%) | 1671 (8.0%) | 471 (8.0%) | 2762 (8.3%) | |
Mortality | < 0.0011 | ||||||
   Deceased | 754 (81.1%) | 795 (69.1%) | 840 (19.1%) | 3634 (17.3%) | 614 (10.4%) | 6637 (19.9%) | |
   Survived | 176 (18.9%) | 356 (30.9%) | 3569 (80.9%) | 17368 (82.7%) | 5281 (89.6%) | 26750 (80.1%) | |
Survival (months) | < 0.0012 | ||||||
   Mean (SD) | 15.88 (24.91) | 22.37 (29.54) | 49.69 (64.39) | 58.03 (77.33) | 57.50 (71.17) | 54.43 (73.08) | |
   Median | 8.05 | 12.47 | 28.93 | 34.87 | 36.57 | 32.20 | |
   Q1,Q3 | 2.58, 18.18 | 3.52, 29.40 | 9.60, 66.17 | 12.50, 73.46 | 14.57, 71.95 | 11.07, 69.57 |
Pan-disease (N=4409) | Control (N=5895) | Total (N=10304) | p value | |
---|---|---|---|---|
Gender | < 0.0011 | |||
   Female | 2043 (46.3%) | 1681 (28.5%) | 3724 (36.1%) | |
   Male | 2366 (53.7%) | 4214 (71.5%) | 6580 (63.9%) | |
Ethnicity | < 0.0011 | |||
   White | 2370 (57.6%) | 3280 (57.7%) | 5650 (57.7%) | |
   South Asian | 874 (21.2%) | 942 (16.6%) | 1816 (18.5%) | |
   Black | 408 (9.9%) | 806 (14.2%) | 1214 (12.4%) | |
   Far/South-east Asian | 19 (0.5%) | 31 (0.5%) | 50 (0.5%) | |
   Arab/North African | 1 (0.0%) | 5 (0.1%) | 6 (0.1%) | |
   Asian (Other) | 178 (4.3%) | 234 (4.1%) | 412 (4.2%) | |
   Mixed | 49 (1.2%) | 78 (1.4%) | 127 (1.3%) | |
   Other | 217 (5.3%) | 306 (5.4%) | 523 (5.3%) | |
Diagnosis age (years) | < 0.0012 | |||
   Mean (SD) | 52.90 (18.51) | 54.77 (17.59) | 53.97 (18.01) | |
   Median | 51.28 | 54.09 | 53.02 | |
   Q1,Q3 | 38.36, 67.20 | 41.02, 68.00 | 39.78, 67.70 | |
Diagnosis age group | < 0.0011 | |||
   18-40 | 1318 (29.9%) | 1470 (24.9%) | 2788 (27.1%) | |
   41-50 | 862 (19.6%) | 1097 (18.6%) | 1959 (19.0%) | |
   51-60 | 773 (17.5%) | 1163 (19.7%) | 1936 (18.8%) | |
   61-70 | 574 (13.0%) | 961 (16.3%) | 1535 (14.9%) | |
   71-80 | 519 (11.8%) | 733 (12.4%) | 1252 (12.2%) | |
   >80 | 363 (8.2%) | 471 (8.0%) | 834 (8.1%) | |
Mortality | < 0.0011 | |||
   Deceased | 840 (19.1%) | 614 (10.4%) | 1454 (14.1%) | |
   Survived | 3569 (80.9%) | 5281 (89.6%) | 8850 (85.9%) | |
Survival (months) | < 0.0012 | |||
   Mean (SD) | 49.69 (64.39) | 57.50 (71.17) | 54.16 (68.46) | |
   Median | 28.93 | 36.57 | 33.20 | |
   Q1,Q3 | 9.60, 66.17 | 14.57, 71.95 | 12.47, 69.70 |
Pan-disease (N=4409) | Control (N=5895) | Total (N=10304) | p value | |
---|---|---|---|---|
Comorbidity | < 0.0011 | |||
   Mean (SD) | 2.73 (2.24) | 1.92 (1.87) | 2.27 (2.07) | |
   Median | 2.00 | 1.00 | 2.00 | |
   Q1,Q3 | 1.00, 4.00 | 0.00, 3.00 | 1.00, 4.00 | |
Diabetes | 1354 (30.7%) | 1010 (17.1%) | 2364 (22.9%) | < 0.0012 |
Hypertension | 2168 (49.2%) | 2545 (43.2%) | 4713 (45.7%) | < 0.0012 |
Cholesterol | 1831 (41.5%) | 2226 (37.8%) | 4057 (39.4%) | < 0.0012 |
Asthma | 730 (16.6%) | 874 (14.8%) | 1604 (15.6%) | 0.0162 |
COPD | 315 (7.1%) | 306 (5.2%) | 621 (6.0%) | < 0.0012 |
TB | 79 (1.8%) | 67 (1.1%) | 146 (1.4%) | 0.0052 |
Kidney | 844 (19.1%) | 821 (13.9%) | 1665 (16.2%) | < 0.0012 |
Cardiovascular | 1091 (24.7%) | 1362 (23.1%) | 2453 (23.8%) | 0.0532 |
Upper GI | 1459 (33.1%) | 1287 (21.8%) | 2746 (26.6%) | < 0.0012 |
Lower GI | 541 (12.3%) | 682 (11.6%) | 1223 (11.9%) | 0.2762 |
F/H: Cancer | 1017 (23.1%) | 1141 (19.4%) | 2158 (20.9%) | < 0.0012 |
F/H: Digestive | 117 (2.7%) | 120 (2.0%) | 237 (2.3%) | 0.0382 |
F/H: Diabetes | 1176 (26.7%) | 1484 (25.2%) | 2660 (25.8%) | 0.0852 |
Pan-disease (N=4409) | Control (N=5895) | Total (N=10304) | p value | |
---|---|---|---|---|
Smoker | < 0.0011 | |||
   Not available | 679 (15.4%) | 481 (8.2%) | 1160 (11.3%) | |
   Never | 1419 (32.2%) | 2278 (38.6%) | 3697 (35.9%) | |
   Past | 997 (22.6%) | 1767 (30.0%) | 2764 (26.8%) | |
   Current | 1314 (29.8%) | 1369 (23.2%) | 2683 (26.0%) | |
Drinker | < 0.0011 | |||
   Not available | 1114 (25.3%) | 1228 (20.8%) | 2342 (22.7%) | |
   Never | 868 (19.7%) | 1340 (22.7%) | 2208 (21.4%) | |
   Past | 229 (5.2%) | 291 (4.9%) | 520 (5.0%) | |
   Current | 2198 (49.9%) | 3036 (51.5%) | 5234 (50.8%) | |
Substance user | < 0.0011 | |||
   Not available | 2551 (57.9%) | 2739 (46.5%) | 5290 (51.3%) | |
   Never | 712 (16.1%) | 2117 (35.9%) | 2829 (27.5%) | |
   Past | 31 (0.7%) | 37 (0.6%) | 68 (0.7%) | |
   Current | 1115 (25.3%) | 1002 (17.0%) | 2117 (20.5%) | |
Obese | < 0.0011 | |||
   Not available | 634 (14.4%) | 540 (9.2%) | 1174 (11.4%) | |
   Never | 1106 (25.1%) | 1269 (21.5%) | 2375 (23.0%) | |
   Past | 1531 (34.7%) | 2539 (43.1%) | 4070 (39.5%) | |
   Current | 1138 (25.8%) | 1547 (26.2%) | 2685 (26.1%) |
Pan-disease (N=3439) | Control (N=5074) | Total (N=8513) | p value | |
---|---|---|---|---|
Gender | < 0.0011 | |||
   Female | 1583 (46.0%) | 1457 (28.7%) | 3040 (35.7%) | |
   Male | 1856 (54.0%) | 3617 (71.3%) | 5473 (64.3%) | |
Ethnicity | < 0.0011 | |||
   White | 1838 (53.7%) | 2788 (55.5%) | 4626 (54.8%) | |
   South Asian | 842 (24.6%) | 898 (17.9%) | 1740 (20.6%) | |
   Black | 374 (10.9%) | 755 (15.0%) | 1129 (13.4%) | |
   Far/South-east Asian | 17 (0.5%) | 29 (0.6%) | 46 (0.5%) | |
   Arab/North African | 1 (0.0%) | 5 (0.1%) | 6 (0.1%) | |
   Asian (Other) | 162 (4.7%) | 219 (4.4%) | 381 (4.5%) | |
   Mixed | 41 (1.2%) | 71 (1.4%) | 112 (1.3%) | |
   Other | 147 (4.3%) | 260 (5.2%) | 407 (4.8%) | |
Diagnosis age (years) | < 0.0012 | |||
   Mean (SD) | 52.54 (18.34) | 53.84 (17.18) | 53.32 (17.67) | |
   Median | 50.69 | 53.14 | 52.11 | |
   Q1,Q3 | 38.21, 66.39 | 40.29, 66.68 | 39.48, 66.54 | |
Diagnosis age group | < 0.0011 | |||
   18-40 | 1051 (30.6%) | 1326 (26.1%) | 2377 (27.9%) | |
   41-50 | 690 (20.1%) | 991 (19.5%) | 1681 (19.7%) | |
   51-60 | 610 (17.7%) | 1010 (19.9%) | 1620 (19.0%) | |
   61-70 | 432 (12.6%) | 820 (16.2%) | 1252 (14.7%) | |
   71-80 | 370 (10.8%) | 581 (11.5%) | 951 (11.2%) | |
   >80 | 286 (8.3%) | 346 (6.8%) | 632 (7.4%) | |
Mortality | < 0.0011 | |||
   Deceased | 618 (18.0%) | 483 (9.5%) | 1101 (12.9%) | |
   Survived | 2821 (82.0%) | 4591 (90.5%) | 7412 (87.1%) | |
Survival (months) | < 0.0012 | |||
   Mean (SD) | 57.69 (69.11) | 64.21 (73.97) | 61.57 (72.11) | |
   Median | 35.47 | 42.40 | 39.87 | |
   Q1,Q3 | 15.12, 74.20 | 19.81, 78.11 | 17.83, 77.03 |
Pan-disease (N=3439) | Control (N=5074) | Total (N=8513) | p value | |
---|---|---|---|---|
Comorbidity | < 0.0011 | |||
   Mean (SD) | 3.09 (2.27) | 1.99 (1.92) | 2.43 (2.14) | |
   Median | 3.00 | 2.00 | 2.00 | |
   Q1,Q3 | 1.00, 5.00 | 0.00, 3.00 | 1.00, 4.00 | |
Diabetes | 1124 (32.7%) | 884 (17.4%) | 2008 (23.6%) | < 0.0012 |
Hypertension | 1866 (54.3%) | 2183 (43.0%) | 4049 (47.6%) | < 0.0012 |
Cholesterol | 1692 (49.2%) | 2065 (40.7%) | 3757 (44.1%) | < 0.0012 |
Asthma | 644 (18.7%) | 783 (15.4%) | 1427 (16.8%) | < 0.0012 |
COPD | 259 (7.5%) | 237 (4.7%) | 496 (5.8%) | < 0.0012 |
TB | 78 (2.3%) | 66 (1.3%) | 144 (1.7%) | < 0.0012 |
Kidney | 727 (21.1%) | 679 (13.4%) | 1406 (16.5%) | < 0.0012 |
Cardiovascular | 927 (27.0%) | 1131 (22.3%) | 2058 (24.2%) | < 0.0012 |
Upper GI | 1405 (40.9%) | 1266 (25.0%) | 2671 (31.4%) | < 0.0012 |
Lower GI | 530 (15.4%) | 653 (12.9%) | 1183 (13.9%) | < 0.0012 |
F/H: Cancer | 1017 (29.6%) | 1141 (22.5%) | 2158 (25.3%) | < 0.0012 |
F/H: Digestive | 108 (3.1%) | 116 (2.3%) | 224 (2.6%) | 0.0162 |
F/H: Diabetes | 1171 (34.1%) | 1482 (29.2%) | 2653 (31.2%) | < 0.0012 |
Pan-disease (N=3439) | Control (N=5074) | Total (N=8513) | p value | |
---|---|---|---|---|
Smoker | < 0.0011 | |||
   Not available | 12 (0.3%) | 16 (0.3%) | 28 (0.3%) | |
   Never | 1312 (38.2%) | 2130 (42.0%) | 3442 (40.4%) | |
   Past | 955 (27.8%) | 1685 (33.2%) | 2640 (31.0%) | |
   Current | 1160 (33.7%) | 1243 (24.5%) | 2403 (28.2%) | |
Drinker | 0.2561 | |||
   Not available | 449 (13.1%) | 674 (13.3%) | 1123 (13.2%) | |
   Never | 779 (22.7%) | 1204 (23.7%) | 1983 (23.3%) | |
   Past | 227 (6.6%) | 288 (5.7%) | 515 (6.0%) | |
   Current | 1984 (57.7%) | 2908 (57.3%) | 4892 (57.5%) | |
Substance user | < 0.0011 | |||
   Not available | 1828 (53.2%) | 2237 (44.1%) | 4065 (47.8%) | |
   Never | 630 (18.3%) | 1965 (38.7%) | 2595 (30.5%) | |
   Past | 28 (0.8%) | 33 (0.7%) | 61 (0.7%) | |
   Current | 953 (27.7%) | 839 (16.5%) | 1792 (21.1%) | |
Obese | < 0.0011 | |||
   Not available | 65 (1.9%) | 101 (2.0%) | 166 (1.9%) | |
   Never | 933 (27.1%) | 1174 (23.1%) | 2107 (24.8%) | |
   Past | 1420 (41.3%) | 2400 (47.3%) | 3820 (44.9%) | |
   Current | 1021 (29.7%) | 1399 (27.6%) | 2420 (28.4%) |